¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"IF"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
IF   1) Immuno-Fluorescence
  2) Intrinsic Factor
IF idiopathic fibroplasia; idiopathic flushing; immersion foot; immunofluorescence; indirect fluorescence; infrared; inhibiting factor; initiation factor; instantaneous flow; interferon; interior facet; intermediate filament; intermediate frequency; internal fixation; interstitial fluid;interventional fluoroscopy; intrinsic factor; involved field [radiotherapy]
If nec if necessary
IF test Immuno-Fluorescence test
IF1, IF2, IF3 interferon 1, 2, 3
IFA Immuno-Fluorescence Antibody Test(= Assay)
IFA idiopathic fibrosing alveolitis; immunofluorescence assay; immunofluorescent antibody; incomplete Freund's adjuvant; indirect fluorescent antibody; indirect fluorescent assay; International Fertility Association; International Filariasis Association
IFA test Indirect Fluorescent Antibody test
IFAP ichthyosis follicularis-atrichia-photophobia [syndrome]
IFAT indirect fluorescent antibody test
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
IF 2-interferon
IF Ifosfamide
IF Immunofluorescence
IF Impact Factor
IF Initiation factor
IF Intermediate Filament
IF Intermediate-sized filaments
IF Interstitial fluid
IF Intrinsic Factor
IF Involved field
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 29148
    JournalTitle: IFO-Studien.
    MedAbbr: IFO Stud
    ISSN: 0018-9731
    ESSN:
    IsoAbbr:
    NlmId: 101087597
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • IF
    "(å²) initiation factor, intrinsic factor, isoelectric focusing, intermediate filament"
  • IFMA
    (å²) immunofluorometric assay
  • IFN
    (å²) interferon
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
IF <abbreviation> Initiation factor; intrinsic factor.
(05 Mar 2000)
IFN <abbreviation> Interferon.
(05 Mar 2000)
IFN-a <abbreviation> Interferon-alpha.
(05 Mar 2000)
IFN-b <abbreviation> Interferon-beta.
(05 Mar 2000)
IFN-g <abbreviation> Interferon-gamma.
(05 Mar 2000)
ifosfamide <chemical> 3-(2-chloroethyl)-2-(2-chloroethylamino)tetrahydro-2h-1,3,2-oxazaphosphorine 2-oxide. Positional isomer of cyclophosphamide which is active as an alkylating agent and an immunosuppressive agent.
Pharmacological action: antineoplastic agent, alkylating, immunosuppressive agents.
Chemical name: 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Ifosfamide - »õâ Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent.
    Synonyms : Asta Z 4942, Holoxan, Iphosphamide, Iso-Endoxan, NSC-109, 724, NSC-109724, Iso Endoxan, NSC 109, 724, NSC 109724, NSC109, 724, NSC109724
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 3 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÆä³ë½ÅÁ¤ - »õâ
½Å½ÅÁ¦¾à
A10900481 Ibuprofen
ÀϹÝÀǾàǰ | »èÁ¦
Áß¿ÜÀÌÆ÷½ºÆÄ¸¶À̵åÁÖ - »õâ
Áß¿Ü
A02150311 Ifosfamide
Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ
À̼ӻêÁÖ1000mg - »õâ
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à
A12941581 Ifosfamide
Àü¹®ÀǾàǰ | ±Þ¿©
Ȧ·Ï»êÁÖ1000mg - »õâ
ASTA
A13150421 Ifosfamide
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
ÀÌÆå»ç½ÅÁÖ - »õâ
½ÅdzÁ¦¾à
A00303441 Pefloxacin methanesulfonate
Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ
ºÎ±¤¹Ùµð·º½ºÁ¤ - »õâ
ºÎ±¤¾àǰ
A13101761 Ifenprodil Tartrate
Àü¹®ÀǾàǰ | »èÁ¦
À̽ºÆÄÁÖ»ç - »õâ
ºñ¾¾¿ùµåÁ¦¾à
A16251491 Ifosfamide
Àü¹®ÀǾàǰ | »èÁ¦
ÀÌÆä³ë½ÅÁ¤400mg - »õâ
½Å½ÅÁ¦¾à
A10900981 Ibuprofen
ÀϹÝÀǾàǰ | »èÁ¦
À¯´Ï¿ÂÀÌÆ÷½ºÆÄ¸¶À̵åÁÖ - »õâ
Çѱ¹À¯´Ï¿ÂÁ¦¾à
A12254451 Ifosfamide
Àü¹®ÀǾàǰ | ±Þ¿©
ÀÌÆåÆ®¶óĸ½¶ - »õâ
Á¾±Ù´ç
A01207461 Itraconazole
Àü¹®ÀǾàǰ | ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 7 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IF if, subtitled "Worlds of Science Fiction", was launched in March 1952, the creation, apparently, of James L. Quinn of the Quinn Publishing Company, not to be confused with Robert Guinn, who later published both If and its sister magazine Galaxy. (The title "If" had previously been used by Con Perderson in 1948 for an amateur magazine. ...
Ãâó: en.wikipedia.org/wiki/If_(magazine)
IFA IFA may stand for: *Institut für Fabrikanlagen und Logistik an der Universität Hannover*Institute of Field Archaeologists (UK)*Internationale Funkausstellung (International Radio Exhibition), the German consumer show which is held annually in Berlin, Germany. ...
Ãâó: en.wikipedia.org/wiki/IFA
Ifosfamide An anticancer drug that belongs to the family of drugs called alkylating agents.
Ãâó: www.stjude.org/glossary
IF Abbreviation for intermediate frequency.
Ãâó: amsglossary.allenpress.com/glossary/browse
IF Indicates a conditional transaction in a security that is authorized for issuance, but not issued yet. New primary offerings can trade on an "if, as and when" issued basis prior to listing on an exchange.
Ãâó: https://www.bmoinvestorline.com/EducationCentre/i....
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • if
    ¸¸ÀÏ...À̸é
  • IF
    intermediate frequency
  • if
  • IFAD
    International Fund for Agricultural Development(À¯¿£)±¹Á¦ ³ó¾÷ °³¹ß ±â±Ý
  • IFC
    International Finance Corporation
  • ifclause
    Á¶°ÇÀý 
  • IFCTU
    International Federation of Christian Trade Unions
  • IFF
    identification friend or foe (ºñÇà±â,±ºÇÔµîÀÇ)ÇǾƽĺ°ÀåÄ¡
  • iffy
    ºÒÈ®½ÇÇÑ;Àǽɽº·¯¿î;Á¶°ÇºÎÀÇ;´Ù±¹Àû ±¹Á¦ ±ÝÀ¶±â°ü
  • IFO
    identified flying objectÈ®ÀÎ ºñÇ๰ü
  • IFR
    instrument flight rules °è±â ºñÇà ¹æ½Ä
  • IFRB
    International Frequency Registration Board ±¹Á¦ Á֯ļö µî·Ï À§¿øÈ¸
  • IFTA
    International Federation of Travel Agencies
  • IFTU
    International Federation of Trade Unions±¹Á¦ ³ëµ¿ Á¶ÇÕ¿¬ÇÕȸ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
IF perhaps
IF a United Nations agency that invest directly in companies and guarantees loans to private investors
IF (informal) subject to accident or chance or change
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 1
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á